|
|
|
Two plead guilty to distributing heroin
Court News |
2011/11/15 11:24
|
Two Kansas residents have pleaded guilty to distributing heroin in Wichita in a case that also involved 10 other people.
The U.S. Attorney's office says 28-year-old Patrice Chadwick, of Wichita, and 30-year-old Christopher Schneider, of Rose Hill, entered the pleas Tuesday in federal court.
Chadwick admitted that in October 2010, she picked up 50 packets of heroin that another woman had left in a supermarket restroom and delivered it to a third defendant. Chadwick also admitted receiving 100 packets of heroin mailed to her from New York by another defendant in the case.
In his plea, Schneider admitted delivering two bags of heroin to another woman at her workplace.
Eleven of the 12 people charged in the case have pleaded guilty, while one other is awaiting trial.
|
|
|
|
|
|
|
Justices unlikely to have last word on health care
Court Watch |
2011/11/15 08:59
|
President Barack Obama's historic health care overhaul divided the nation from the day he signed it into law, and that seems unlikely to change no matter how the Supreme Court rules on its constitutionality.
Some legal disputes, like the 2008 presidential election, the court can settle. Others rage on, such as abortion. It may take another decade to find the balance between private and public responsibility for health care in America, a nation disdainful of big government yet historically unable to guarantee affordable basic coverage to its citizens.
"Either way it rules, the Supreme Court decision will not end the debate on health care," said former Senate Majority Leader Tom Daschle, an influential Democratic adviser. "It is, and will largely remain, a debate on the role of government."
The Supreme Court's announcement on Monday that it will take up the constitutional challenge to what Republicans deride as "Obamacare," sets the stage for a decision next summer in the heat of the presidential election campaign.
|
|
|
|
|
|
|
UIHC Social Worker Fired After Guilty Plea
Attorney News |
2011/11/14 11:24
|
The University of Iowa Hospitals and Clinics has fired a veteran social worker weeks after he pleaded guilty to disorderly conduct following an arrest on charges that he assaulted his teenage daughter.
UI spokesman Tom Moore said last week that Frank Sammet's "term of service" ended Oct. 19 but would not say whether he resigned or was fired. After repeated follow-up questions and an appeal to his superior by The Associated Press, Moore acknowledged Sammet was fired but wouldn't say why.
The firing is a change for the university, which had allowed Sammet to continue seeing patients for months even as he was fighting a domestic abuse charge alleging that he choked, punched and kicked his 18-year-old daughter Feb. 2.
|
|
|
|
|
|
|
Russia court rejects $16 billion claim against BP
Court News |
2011/11/14 11:24
|
A Russian court on Friday rejected a $16 billion claim against BP PLC filed by an obscure minority shareholder in BP's Russian venture, TNK-BP.
The court victory may have softened the blow that BP sustained when Rosneft dropped it as a partner in developing Russia's untapped Arctic oil and gas riches. The multibillion dollar deal broke down after TNK-BP's Russian billionaire shareholders blocked it, claiming that BP should be pursuing it through TNK-BP.
The Arbitration Court in the Tyumen region in Siberia on Friday dismissed two motions filed by a group of minority shareholders led by Andrei Prokhorov, who owns 0.0000106 percent in TNK-BP. The lawsuits are a $13 billion claim against BP and a $2.8 billion suit against two BP-nominated directors on TNK-BP's board.
Prokhorov and other shareholders claimed that BP and its representatives damaged TNK-BP's interests by failing to include the Russian venture in the Arctic deal with Rosneft.
BP's Russian partners in TNK-BP have denied any connection to the minority shareholder's suit. The claim was the reason why Russian police raided BP's office in August, which happened just days after Rosneft teamed up with ExxonMobil to develop the Arctic. |
|
|
|
|
|
|
Scott+Scott LLP Announces Securities Class Action Lawsuit
Court Watch |
2011/11/14 11:24
|
Scott+Scott LLP filed a class action complaint against Human Genome Sciences, Inc., certain of the Company's senior officers and directors and GlaxoSmithKline plc in the U.S. District Court for the District of Maryland. The action for violations of the Securities Exchange Act of 1934 is brought on behalf of those purchasing the common stock of HGSI between July 20, 2009 and November 11, 2010, inclusive (the "Class Period"), including all persons who acquired the common stock of HGSI in the Company's July 28, 2009 public offering at $14 per share and in its December 2, 2009 public offering of common stock at $26.75.
If you purchased the common stock of HGSI during the Class Period and wish to serve as a lead plaintiff in the action, you must move the Court no later than 60 days from today. Any member of the investor class may move the Court to serve as lead plaintiff through counsel of its choice, or may choose to do nothing and remain an absent class member. If you wish to discuss this action or have questions concerning this notice or your rights, please contact Scott+Scott (scottlaw@scott-scott.com), (800) 404-7770, (860) 537-5537 or visit the Scott+Scott HGSI Pharmaceutical website for more information: www.scott-scott.com/cases/hgs.html. There is no cost or fee to you.
The complaint filed in the action alleges that, during the Class Period, HGSI issued false and misleading statements concerning Benlysta(R) (belimumab) ("Benlysta"), the Company's potential new drug for the treatment of Systemic Lupus Erythematosus, a chronic, life-threatening autoimmune disease. Specifically, the complaint alleges that defendants failed to disclose that Benlysta was associated with suicide in clinical drug trials conducted by the Company.
The complaint alleges that when the U.S. Food and Drug Administration posted its analysis of Benlysta on the Internet on November 12, 2010, investors learned for the first time of the association between Benlysta and suicide in clinical trials of the drug, causing HGSI's common stock price to decline precipitously. Meanwhile, the complaint alleges, during the Class Period, HGSI sold to investors more than 44 million shares of its common stock in public offerings at artificially inflated prices, receiving $850 million in net proceeds.
Scott+Scott has significant experience in prosecuting major securities, antitrust and employee retirement plan actions throughout the United States. The firm represents pension funds, foundations, individuals and other entities worldwide. |
|
|
|
|
|
Legal News RSS Feed
